|
| |
| | | 67109 | | 18.04.2019 | | Janssen-Cilag AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Imbruvica 140 mg | Filmtabletten | Coated tablets (Ibrutinibum 140 mg) | L01EL01 | CI | | 02 | Imbruvica 280 mg | Filmtabletten | Coated tablets (Ibrutinibum 280 mg) | L01EL01 | | | 03 | Imbruvica 420 mg | Filmtabletten | Coated tablets (Ibrutinibum 420 mg) | L01EL01 | | | 04 | Imbruvica 560 mg | Filmtabletten | Coated tablets (Ibrutinibum 560 mg) | L01EL01 | |
|
|
|
